Updates are available Correction dated 2026-03-12

Article History

Received: 24 October 2025

Accepted: 2 January 2026

First Online: 27 January 2026

Change Date: 12 March 2026

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s12325-026-03532-4

Declarations

:

: María R. Abad: I declare that I have received honoraria for the development of this project from argenx and speakers’ fees from UCB Pharma, Johnson & Johnson, Vertex, Organon, Biogen, CINFA, Astra Zeneca, GSK, and Sanofi Aventis. Elena Cortés-Vicente: I declare that I have received honoraria for speaking engagements and consultancy activities from argenx, UCB, Alexion, and Janssen. Francisco J. Toja-Camba: I declare that I have received honoraria for the development of this project from argenx. Carmina Díaz: I declare that I have received honoraria for the development of this project from argenx. Included received speakers fees from ALEXION and UCB. Eva Martínez: I declare that I have received honoraria for the development of this project from argenx. José M. Serra: I declare that I have received honoraria for the development of this project from argenx. Jose L. Trillo: I declare that I have received honoraria for the development of this project from argenx. Antonio Guerrero: I declare that I have received honoraria for the development of this project from argenx and received speaker’s fees from ALEXION and UCB.

: The authors declare that no experiments on humans or animals have been carried out for this research. The authors declare that no patient data appear in this article. Full consent to participate in the study and to publish the findings was obtained from all contributors.